However, it is not known how IGF-1R and its signaling axis impacts CD4+ T cell differentiation into different CD4+ T cell subsets and the progression of EAE/MS and further investigation into IGF-1R on CD4+ T cell differentiation is currently under investigation. Here, IGF1R is linked to myeloid sarcoma.